KAUFMANN GUNNAR F. (Chief Scientific Officer) purchased 42.0% of their position (28K shares) of ONCTERNAL THERAPEUTICS, INC. on the open market
Open‑market purchase worth $9.8K — a major conviction buy. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 6/14/2023ACC: 0001209191-23-036994
Officer· Chief Scientific Officer
Since Sep 2019
+28K
Net shares
Net buyer
$9.8K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
28K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+25K
Price / share
$0.35
Trade value
$8.74K
% of position
37.5%
6/12/2023
66.73K→91.73K
Common Stock
Direct
Shares
+3K
Price / share
$0.36
Trade value
$1.08K
% of position
3.3%
6/14/2023
91.73K→94.73K
Total
Net shares
+28K
Net value
$9.82K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/12/2023 | P · Purchase | +25K | $0.35 | $8.74K | 37.5% | 66.73K | 91.73K |
| Common Stock Direct | 6/14/2023 | P · Purchase | +3K | $0.36 | $1.08K | 3.3% | 91.73K | 94.73K |
| Total | +28K | $9.82K | ||||||
Derivative Transactions0
No derivative transactions reported